Profiel
Taku Nakahara is the founder and current President, CEO & Representative Director of Metagen Therapeutics, Inc. which is founded in 2020.
He is also currently a Venture Partner at Fast Track Initiative, Inc. where he started in 2019.
Actieve functies van Taku Nakahara
| Bedrijven | Functie | Begin |
|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Private Equity Investor | 01-01-2019 |
Metagen Therapeutics, Inc.
 Metagen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Metagen Therapeutics, Inc. is a company based in Tsuruoka, Japan. The Japanese company was founded in 2020 by Taku Nakahara, Takuji Yamada, Shinji Fukuda, and Dai Ishikawa. Taku Nakahara has been the CEO since 2020. | Oprichter | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Finance |
Metagen Therapeutics, Inc.
Metagen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Metagen Therapeutics, Inc. is a company based in Tsuruoka, Japan. The Japanese company was founded in 2020 by Taku Nakahara, Takuji Yamada, Shinji Fukuda, and Dai Ishikawa. Taku Nakahara has been the CEO since 2020. | Commercial Services |
